The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Autocrine/Paracrine Prostaglandin E2 Production by Non-small Cell Lung Cancer Cells Regulates Matrix Metalloproteinase-2 and CD44 in Cyclooxygenase-2-dependent Invasion
Open accessAbstract
Tumor cyclooxygenase-2 (COX-2) expression is known to be associated with enhanced tumor invasiveness. In the present study, we evaluated the importance of the COX-2 product prostaglandin E2 (PGE2) and its signaling through the EP4 receptor in mediating non-small cell lung cancer (NSCLC) invasiveness. Genetic inhibition of tumor COX-2 led to diminished matrix metalloproteinase (MMP)-2, CD44, and EP4 receptor expression and invasion. Treatment of NSCLC cells with exogenous 16,16-dimethylprostaglandin E2 significantly increased EP4 receptor, CD44, and MMP-2 expression and matrigel invasion. In contrast, anti-PGE2 decreased EP4 receptor, CD44, and MMP-2 expression in NSCLC cells. EP4 receptor signaling was found to be central to this process, because antisense oligonucleotide-mediated inhibition of tumor cell EP4 receptors significantly decreased CD44 expression. In addition, agents that increased intracellular cAMP, as is typical of EP4 receptor signaling, markedly increased CD44 expression. Moreover, MMP-2-AS treatment decreased PGE2-mediated CD44 expression, and CD44-AS treatment decreased MMP-2 expression. Thus, PGE2-mediated effects through EP4 required the parallel induction of both CD44 and MMP-2 expression because genetic inhibition of either MMP-2 or CD44 expression effectively blocked PGE2-mediated invasion in NSCLC. These findings indicate that PGE2 regulates COX-2-dependent, CD44- and MMP-2-mediated invasion in NSCLC in an autocrine/paracrine manner via EP receptor signaling. Thus, blocking PGE2 production or activity by genetic or pharmacological interventions may prove to be beneficial in chemoprevention or treatment of NSCLC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tsujii, M., & DuBois, R. N. (1995) · Cell · doi:10.1016/0092-8674(95)90127-2 · Cited by 2,267
Yu, Q., & Stamenkovic, I. (2000) · PubMed · Cited by 1,995
Yu, Q., & Stamenkovic, I. (2000) · Genes & Development · doi:10.1101/gad.14.2.163 · Cited by 1,754
Coleman, R. A., Smith, W. L., & Narumiya, S. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06784-5 · Cited by 1,735
Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.
Masferrer, J. L., Leahy, K. M., Koki, A. T., Zweifel, B. S., Settle, S. L., Woerner, B. M., Edwards, D. A., Flickinger, A. G., Moore, R. J., & Seibert, K. (2000) · PubMed · Cited by 1,401
Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential
Tsujii, M., Kawano, S., & DuBois, R. N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3336 · Cited by 1,398
Herschman, H. R. (1996) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(95)00194-8 · Cited by 1,197
Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells.
Sheng, H., Shao, J., Morrow, J. D., Beauchamp, R. D., & Dubois, R. N. (1998) · PubMed · Cited by 1,114
COX-2 is expressed in human pulmonary, colonic, and mammary tumors
Soslow, R. A., Dannenberg, A. J., Rush, D., Woerner, B. M., Khan, K. N., Masferrer, J., & Koki, A. T. (2000) · Cancer · doi:10.1002/1097-0142(20001215)89:12<2637::aid-cncr17>3.0.co;2-b · Cited by 862
Hida, T., Yatabe, Y., Achiwa, H., Muramatsu, H., Kozaki, K., Nakamura, S., Ogawa, M., Mitsudomi, T., Sugiura, T., & Takahashi, T. (1998) · PubMed · Cited by 818
Membrane-Type 1 Matrix Metalloproteinase Cleaves Cd44 and Promotes Cell Migration
Kajita, M., Itoh, Y., Chiba, T., Mori, H., Okada, A., Kinoh, H., & Seiki, M. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.5.893 · Cited by 746
Expression of cyclooxygenase-2 in human lung carcinoma.
Wolff, H. J., Saukkonen, K., Anttila, S. L., Karjalainen, A., Vainio, H., & Ristimaki, A. P. (1998) · PubMed · Cited by 717
Yu, Q., & Stamenkovic, I. (1999) · Genes & Development · doi:10.1101/gad.13.1.35 · Cited by 713
Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck.
Chan, G. G., Boyle, J. O., Yang, E. K., Zhang, F., Sacks, P. G., Shah, J. P., Edelstein, D. R., Soslow, R. A., Koki, A. T., Woerner, B. M., et al. (1999) · PubMed · Cited by 706
Matrix metalloproteinases and metastasis
Kleiner, D. E., & Stetler-Stevenson, W. G. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800051097 · Cited by 701
Host cyclooxygenase-2 modulates carcinoma growth
Williams, C. S., Tsujii, M., Reese, J., Dey, S. K., & DuBois, R. N. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9621 · Cited by 673
Prostaglandin E2 Increases Growth and Motility of Colorectal Carcinoma Cells
Sheng, H., Shao, J., Washington, M. K., & DuBois, R. N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009689200 · Cited by 653
Molecular insights into cancer invasion: strategies for prevention and intervention.
Kohn, E. C., & Liotta, L. A. (1995) · PubMed · Cited by 496
Huang, M., Stolina, M., Sharma, S. P., Mao, J. T., Zhu, L. X., Miller, P. W., Wollman, J. S., Herschman, H. R., & Dubinett, S. M. (1998) · PubMed · Cited by 492
Self-citationStolina, M., Sharma, S., Lin, Y., Dohadwala, M., Gardner, B., Luo, J., Zhu, L., Kronenberg, M., Miller, P. W., Portanova, J., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.361 · Cited by 465
Self-citationMolina, M. A., Sitjà, M., Lemoine, M. G., Frazier, M. L., & Sinicrope, F. A. (1999) · PubMed · Cited by 404
INHIBITION OF CYCLOOXYGENASE-2 SUPPRESSES ANGIOGENESIS AND THE GROWTH OF PROSTATE CANCER IN VIVO
LIU, X. H., KIRSCHENBAUM, A., YAO, S., LEE, R., HOLLAND, J. F., & LEVINE, A. C. (2000) · Journal of Urology · doi:10.1016/s0022-5347(05)67321-1 · Cited by 363
Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis.
Mutoh, M., Watanabe, K., Kitamura, T., Shoji, Y., Takahashi, M., Kawamori, T., Tani, K., Kobayashi, M., Maruyama, T., Kobayashi, K., et al. (2002) · PubMed · Cited by 362
Inhibition of Cyclooxygenase-2 Gene Expression by p53
Subbaramaiah, K., Altorki, N., Chung, W. J., Mestre, J. R., Sampat, A., & Dannenberg, A. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.10911 · Cited by 355
Regulation of prostaglandin synthase-1 and prostaglandin synthase-2
Herschman, H. R., & Hall, W. (1994) · Cancer and Metastasis Reviews · doi:10.1007/bf00666095 · Cited by 335
Prevention of tumor metastasis formation by anti-variant CD44.
Seiter, S., Arch, R., Reber, S., Komitowski, D., Hofmann, M., Ponta, H., Herrlich, P., Matzku, S., & Zöller, M. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.2.443 · Cited by 334
Bartolazzi, A., Peach, R., Aruffo, A., & Stamenkovic, I. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.53 · Cited by 331
Hida, T., Kozaki, K., Muramatsu, H., Masuda, A., Shimizu, S., Mitsudomi, T., Sugiura, T., Ogawa, M., & Takahashi, T. (2000) · PubMed · Cited by 320
Attiga, F. A., Fernández, P. M., Weeraratna, A. T., Manyak, M. J., & Patierno, S. R. (2000) · PubMed · Cited by 310
Zymography: A Single-Step Staining Method for Quantitation of Proteolytic Activity on Substrate Gels
Leber, T. M., & Balkwill, F. R. (1997) · Analytical Biochemistry · doi:10.1006/abio.1997.2170 · Cited by 299
Cyclooxygenase-2 expression in human pancreatic adenocarcinomas
Yip-Schneider, M. T. (2000) · Carcinogenesis · doi:10.1093/carcin/21.2.139 · Cited by 292
Brown, P. D. N., Bloxidge, R. E., Stuart, N. S. A., Galler, K. C., & Carmichael, J. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.7.574 · Cited by 268
Regulation of Constitutive Cyclooxygenase-2 Expression in Colon Carcinoma Cells
Shao, J., Sheng, H., Inoue, H., Morrow, J. D., & DuBois, R. N. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002324200 · Cited by 257
Uefuji, K., Ichikura, T., & Mochizuki, H. (2000) · PubMed · Cited by 253
Isacke, C. M., & Yarwood, H. (2002) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(01)00166-2 · Cited by 241
Non-small Cell Lung Cancer Cyclooxygenase-2-dependent Invasion Is Mediated by CD44
Dohadwala, M., Luo, J., Zhu, L., Lin, Y., Dougherty, G. J., Sharma, S., Huang, M., Põld, M., Batra, R. K., & Dubinett, S. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100140200 · Cited by 236
Self-citationRole of Cyclooxygenases in Angiogenesis
Leahy, K., Koki, A., & Masferrer, J. (2000) · Current Medicinal Chemistry · doi:10.2174/0929867003374336 · Cited by 197
Huang, M., Sharma, S. P., Mao, J. T., & Dubinett, S. (1996) · Journal of Immunology · doi:10.4049/jimmunol.157.12.5512 · Cited by 184
Self-citationSouthall, M. D., & Vasko, M. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011408200 · Cited by 182
AP-1-Mediated Invasion Requires Increased Expression of the Hyaluronan Receptor CD44
Lamb, R. F., Hennigan, R. F., Turnbull, K., Katsanakis, K. D., MacKenzie, E. D., Birnie, G. D., & Ozanne, B. W. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.2.963 · Cited by 173
Regulation of cell proliferation by G proteins
Dhanasekaran, N., Tsim, S.-T., Dermott, J. M., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1202242 · Cited by 151
Kakiuchi, Y., Tsuji, S., Tsujii, M., Murata, H., Kawai, N., Yasumaru, M., Kimura, A., Komori, M., Irie, T., Miyoshi, E., et al. (2002) · PubMed · Cited by 137
Jabbour, H. N., Milne, S. A., Williams, A. R. W., Anderson, R. A., & Boddy, S. C. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2033 · Cited by 137
Ding, X., Tong, W., & Adrian, T. E. (2000) · PubMed · Cited by 127
Panettieri, R., Lazaar, A. L., Puré, E., & Albelda, S. Μ. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.5.2358 · Cited by 108
Bramhall, S. R. (1997) · International Journal of Pancreatology · doi:10.1007/bf02785914 · Cited by 108
Niki, T., Kohno, T., Iba, S., Moriya, Y., Takahashi, Y., Saito, M., Maeshima, A., Yamada, T., Matsuno, Y., Fukayama, M., et al. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64933-4 · Cited by 97
Chemoprevention of colorectal cancer through inhibition of cyclooxygenase-2.
Dannenberg, A. J., & Zakim, D. (1999) · PubMed · Cited by 93
Progelatinase A activation during tumor cell invasion.
Stetler‐Stevenson, W. G. (1995) · PubMed · Cited by 77
Phosphate removal and hemodialysis conditions
Pohlmeier, R., & Vienken, J. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.59780190.x · Cited by 76
Zhang, Y., Thant, A. A., Machida, K., Ichigotani, Y., Naito, Y., Hiraiwa, Y., Senga, T., Sohara, Y., Matsuda, S., & Hamaguchi, M. (2002) · PubMed · Cited by 76
Ochiai, M., Oguri, T., Isobe, T., Ishioka, S., & Yamakido, M. (1999) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1999.tb00717.x · Cited by 73
Corcoran, M. L., Stetler‐Stevenson, W. G., DeWitt, D. L., et al. (1994) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1994.1196 · Cited by 68
Expression and localization of cyclo-oxygenase isoforms in non-small cell lung cancer
Watkins, D., Lenzo, J. C., Segal, A., Garlepp, M. J., & Thompson, P. J. (1999) · European Respiratory Journal · doi:10.1034/j.1399-3003.1999.14b28.x · Cited by 57
Hyaluronan-induced cyclooxygenase-2 expression promotes thromboxane A2 production by renal cells
Sun, L., Beck‐Schimmer, B., Oertli, B., & Wuthrich, R. P. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00479.x · Cited by 45
Cited by
E-cadherin, β-catenin, and ZEB1 in malignant progression of cancer
Schmalhofer, O., Brabletz, S., & Brabletz, T. (2009) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9179-y · Cited by 765
Sharma, S., Yang, S.-C., Zhu, L., Reckamp, K., Gardner, B., Baratelli, F., Huang, M., Batra, R. K., & Dubinett, S. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0141 · Cited by 506
Self-citationMultiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy
Gately, S., & Li, W. W. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.03.040 · Cited by 398
Smoking and Lung Cancer: The Role of Inflammation
Walser, T., Cui, X., Yanagawa, J., Lee, J. M., Heinrich, E., Lee, G., Sharma, S., & Dubinett, S. M. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200809-100th · Cited by 379
Self-citationRecent advances in molecular biology and physiology of the prostaglandin E2-biosynthetic pathway
Murakami, M., & Kudo, I. (2004) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00037-7 · Cited by 371
Metadata
- Authors
- Dohadwala, M., Batra, R. K., Luo, J., Lin, Y., Krysan, K., Põld, M., Sharma, S., & Dubinett, S. M.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-12
- Volume
- 277
- Issue
- 52
- Pages
- 50828-50833
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2083519527
- Cited by
- 260
- References
- 55
- FWCI
- 11.93
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.